Hepatic steatosis in transgenic mice overexpressing human histone deacetylase 1

Biochemical and Biophysical Research Communications

Volumn 330, Issue 2, 2005, Pages 461-466

  Wang, Ai Guo ^a   Seo, Sang Beom ^b   Moon, Hyung Bae ^c   Shin, Hye Jun ^a   Kim, Dong Hoon ^f   Kim, Jin Man ^d   Lee, Tae Hoon ^e   Kwon, Ho Jeong ^f   Yu, Dae Yeul ^a   Lee, Dong Seok ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chung Ang University   (South Korea)

^c Wonkwang University   (South Korea)

^d Chungnam National University   (South Korea)

^e Chonnam National University   (South Korea)

^f Sejong University   (South Korea)

Author keywords

Histone deacetylase 1; Nuclear pleomorphism; p21; p53; Steatosis

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; HISTONE DEACETYLASE 1; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FATTY LIVER; GENE LOCATION; GENE OVEREXPRESSION; HISTOPATHOLOGY; LIVER CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

EID: 20144374413     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.02.179     Document Type: Article

References (21)

1. J.R. Davie, and M. Moniwa Control of chromatin remodeling Crit. Rev. Eukaryot. Gene Expr. 10 2000 303 325
2. M. Grunstein Histone acetylation in chromatin structure and transcription Nature 389 1997 349 352
3. M.H. Kuo, and C.D. Allis Roles of histone acetyltransferases and deacetylases in gene regulation Bioessays 20 1998 615 626
4. S.G. Gray, and B.T. Teh Histone acetylation/deacetylation and cancer: an "open" and "shut" case? Curr. Mol. Med. 1 2001 401 429
5. C.Y. Gui, L. Ngo, W.S. Xu, V.M. Richon, and P.A. Marks Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1 Proc. Natl. Acad. Sci. USA 101 2004 1241 1246
6. A.J. de Ruijter, A.H. van Gennip, H.N. Caron, S. Kemp, and A.B. van Kuilenburg Histone deacetylases (HDACs): characterization of the classical HDAC family Biochem. J. 370 2003 737 749
7. J. Taunton, C.A. Hassig, and S.L. Schreiber A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p Science 272 1996 408 411
8. W.D. Cress, and E. Seto Histone deacetylases, transcriptional control, and cancer J. Cell Physiol. 184 2000 1 16
9. J. Ahringer NuRD and SIN3 histone deacetylase complexes in development Trends Genet. 16 2000 351 356
10. H.H. Ng, and A. Bird Histone deacetylases: silencers for hire Trends Biochem. Sci. 25 2000 121 126
11. G. Lagger, D. O'Carroll, M. Rembold, H. Khier, J. Tischler, G. Weitzer, B. Schuettengruber, C. Hauser, R. Brunmeir, and T. Jenuwein Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression EMBO J. 21 2002 2672 2681
12. J.H. Choi, H.J. Kwon, B.I. Yoon, J.H. Kim, S.U. Han, H.J. Joo, and D.Y. Kim Expression profile of histone deacetylase 1 in gastric cancer tissues Jpn. J. Cancer Res. 92 2001 1300 1304
13. E. Hu, E. Dul, C.M. Sung, Z. Chen, R. Kirkpatrick, G.F. Zhang, K. Johanson, R. Liu, A. Lago, and G. Hofmann Identification of novel isoform-selective inhibitors within class I histone deacetylases J. Pharmacol. Exp. Ther. 307 2003 720 728
14. D.Y. Yu, H.B. Moon, J.K. Son, S. Jeong, S.L. Yu, H. Yoon, Y.M. Han, C.S. Lee, J.S. Park, and C.H. Lee Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein J. Hepatol. 31 1999 123 132
15. A. Ito, Y. Kawaguchi, C.H. Lai, J.J. Kovacs, Y. Higashimoto, E. Appella, and T.P. Yao MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation EMBO J. 21 2002 6236 6245
16. A.D. Clouston, and E.E. Powell Nonalcoholic fatty liver disease: is all the fat bad? Intern. Med. J. 34 2004 187 191
17. K.J. Tronstad, K. Berge, R.K. Berge, and O. Bruserud Modified fatty acids and their possible therapeutic targets in malignant diseases Expert Opin. Ther. Targets 7 2003 663 677
18. Y. Shi, M. Hon, and R.M. Evans The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling Proc. Natl. Acad. Sci. USA 99 2002 2613 2618
19. A. Aranda, and A. Pascual Nuclear hormone receptors and gene expression Physiol. Rev. 81 2001 1269 1304
20. O. Gavrilova, M. Haluzik, K. Matsusue, J.J. Cutson, L. Johnson, K.R. Dietz, C.J. Nicol, C. Vinson, F.J. Gonzalez, and M.L. Reitman Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass J. Biol. Chem. 278 2003 34268 34276
21. S. Bartl, J. Taplick, G. Lagger, H. Khier, K. Kuchler, and C. Seiser Identification of mouse histone deacetylase 1 as a growth factor-inducible gene Mol. Cell. Biol. 17 1997 5033 5043